Circ-IP6K2 suppresses tumor progression by modulating the miR-1292-5p/CAMK2N1 signal in clear cell renal cell carcinoma
Functional & Integrative Genomics · 2024
DOI: 10.1007/s10142-024-01398-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Functional & Integrative Genomics, 2024. Verfasst von Jian-Ying Tang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, University-Town Hospital of Chongqing Medical University, No 55 road of University-Town, Shapingba District, Chongqing, 401…. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, MicroRNAs, RNA, Circular. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission, National Natural Science Foundation of China.
Abstract (Originalsprache)
Renal cell carcinoma (RCC) is a malignant tumor originating from the epithelial cells of the renal tubules. The clear cell RCC subtype is closely linked to a poor prognosis due to its rapid progression. Circular RNA (circRNA) is a novel class of regulatory RNA molecules that play a role in the development of ccRCC, although their functions have not been fully elucidated. In this study, we identified a significant downregulation of circ-IP6K2 in ccRCC tissues based on data from the GSE100186 dataset. The decreased expression of circ-IP6K2 correlated with the progression of TNM stage and histological grade, and was also associated with decreased overall survival rates in ccRCC patients. Moreover, our findings revealed that circ-IP6K2 expression suppressed proliferation, migration, and invasion capabilities in vitro, and inhibited xenograft growth in vivo. Mechanistically, circ-IP6K2 acted as a sponge for miR-1292-5p in ccRCC cells, which in turn targeted the 3'UTR of CAMK2N1, leading to a decrease in its expression. CAMK2N1 was identified as a tumor suppressor that negatively regulated the β-catenin/c-Myc oncogenic signaling pathway. Additionally, we confirmed a positive correlation between the expression of circ-IP6K2 and CAMK2N1 in ccRCC. Circ-IP6K2 functions to impede the progression of ccRCC by modulating the miR-1292-5p/CAMK2N1 axis. These findings shed new light on the molecular mechanisms driving ccRCC progression and suggest potential therapeutic targets for the treatment of ccRCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, University-Town Hospital of Chongqing Medical University, No 55 road of University-Town, Shapingba District, Chongqing, 401331, P.R. China.
- Department of Urology, Xinqiao Hospital, Third Military Medical University, Chongqing, 400037, China.
- Department of Nephrology, University-Town Hospital of Chongqing Medical University, No 55 road of University-Town, Shapingba District, Chongqing, 401331, P.R. China. 800273@hospital.cqmu.edu.cn.
Förderung
- Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission
- National Natural Science Foundation of China
Zitieren
APA
Tang, J. Y., Yang, L., Wu, Q. J., Yang, Y., Su, Y. Y., Chen, Y. R., & Mu, J. (2024). Circ-IP6K2 suppresses tumor progression by modulating the miR-1292-5p/CAMK2N1 signal in clear cell renal cell carcinoma. Functional & Integrative Genomics. https://doi.org/10.1007/s10142-024-01398-9
Vancouver
Tang JY, Yang L, Wu QJ, Yang Y, Su YY, Chen YR, et al. Circ-IP6K2 suppresses tumor progression by modulating the miR-1292-5p/CAMK2N1 signal in clear cell renal cell carcinoma. Functional & Integrative Genomics. 2024. doi:10.1007/s10142-024-01398-9
BibTeX
@article{Tang2024,
author = {Tang, Jian-Ying and Yang, Lu and Wu, Qing-Jian and Yang, Ying and Su, Yuan-Yuan and Chen, Yi-Rong and Mu, Jiao},
title = {Circ-IP6K2 suppresses tumor progression by modulating the miR-1292-5p/CAMK2N1 signal in clear cell renal cell carcinoma},
journal = {Functional & Integrative Genomics},
year = {2024},
doi = {10.1007/s10142-024-01398-9}
}
EUVIMED